Published in

Springer, CNS Drugs, 11(35), p. 1217-1232, 2021

DOI: 10.1007/s40263-021-00860-7

Links

Tools

Export citation

Search in Google Scholar

Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.

Journal article published in 2021 by Sifat Sharmin, Mathilde Lefort, Bassem Yamout, Eva Kubala Havrdova, Emmanuelle Leray, Maria Trojano, Dana Horakova, Recai Turkoglu, Pierre Grammond, Francois Grand'Maison, Alexandre Prat, Anneke Van der Walt, Marc Girard, Guillermo Izquierdo, Bart Van Wijmeersch and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO